MedTrace Logo

Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA)

NCT01731210 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2018-03-13

No results posted yet for this study

Summary

The LENEA study is an international, prospective, open label, non-randomized multicenter clinical research study designed to assess the safety and effectiveness of the NANO LV lead system.

Conditions

  • LV Lead
  • LV Therapy
  • LV Treatment
  • LV Microcable

Interventions

DEVICE

implantation of the new LV lead: NANO system.

Sponsors & Collaborators

  • LivaNova

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Completion
2013-12-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01731210 on ClinicalTrials.gov